125 related articles for article (PubMed ID: 6263773)
1. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)].
Takada K
Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
Takada K; Yamamoto K; Osato T
Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
Sundar SK; Levine PH; Ablashi DV; Menezes J
Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
Takada K; Osato T
Intervirology; 1979; 11(1):30-9. PubMed ID: 218892
[TBL] [Abstract][Full Text] [Related]
5. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation.
Yang L; Ikeda H; Lai Y; Yoshiki T; Takada K
J Med Virol; 2003 May; 70(1):126-30. PubMed ID: 12629653
[TBL] [Abstract][Full Text] [Related]
7. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
Guan M; Romano G; Henderson EE
Anticancer Res; 1999; 19(4B):3007-17. PubMed ID: 10652585
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
Koizumi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells.
Rickinson AB; Finerty S; Epstein MA
Clin Exp Immunol; 1982 Nov; 50(2):347-54. PubMed ID: 6295671
[TBL] [Abstract][Full Text] [Related]
12. [Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early antigen expression].
Jian SW; Mei CE; Liang YN; Li D; Chen QL; Luo HL; Li YQ; Cai TY
Ai Zheng; 2003 Jan; 22(1):26-9. PubMed ID: 12561431
[TBL] [Abstract][Full Text] [Related]
13. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle.
Teramoto N; Gogolák P; Nagy N; Maeda A; Kvarnung K; Björkholm T; Klein E
J Hum Virol; 2000; 3(3):125-36. PubMed ID: 10881992
[TBL] [Abstract][Full Text] [Related]
16. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
[TBL] [Abstract][Full Text] [Related]
17. [IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon].
Kikuta H
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):46-57. PubMed ID: 3009290
[TBL] [Abstract][Full Text] [Related]
18. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.
Takada K; Osato T
Med Microbiol Immunol; 1981; 170(1):19-26. PubMed ID: 6272076
[TBL] [Abstract][Full Text] [Related]
20. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
